MS GUEST LECTURE Flashcards
2017 McDonald Criteria for MS
diagnosis with MRI
DISSEMINATION IN SPACE:
-lesions in 2 of 4 areas:
-periventricular
-brainstem
-juxtacortical
-spinal cord
DISSEMINATION IN TIME:
-need multiple relapses/new lesions
-need active and nonactive lesions
-inflammatory CSF
- 90% of the brain lesions are asymptomatic
- we consider all new lesions to represent new relapses
Does inflammatory activity go up or down as the disease duration progresses?
inflammatory activity goes down as disease duration increases
WHEREAS brain volume decreases over time
relapse vs pseduorelapse
relapse:
> or equal to 1 symptom from MS with objective neurological deterioration lasting at least 24 hours in the absence of fever and following a neurologically stable period of at least 30 days
pseudorelapse: brief flare-up of old symptoms
caused by anything that temporarily raises affects nerve
transmissions, such as a urinary tract infection, a cold or other virus, exertion during exercise, or high heat and humidity.
Differential diagnosis conditions
acute disseminated encephalomyelitis
neuromyelitis optica
sarcoid
collagen vascular diseases
vasculitis
paraneoplastic antibodies
Hallmarks of MS pathology
mononuclear inflammatory cells
demyelination
relative axon sparing
astrocyte hypertrophy
cervical spinal cord is disproportionately involved
periventricular lesions
PERMANENT DISTABILITY= NEURONAL LOSS
Symptoms of MS depend on the location of:
LESIONS
With transverse myelitis and two or more brain lesions on the first occurrence of a partial myelitis
there is an 88% chance of conversion to MS in the next 20 years
There is often a huge disconnect between the MRI appearance and the _______
clinical appearance
characteristics of lesions in MS
often ovoid and perpendicular to ventricles
What brain areas are commonly atrophied in advanced MS?
corpus callosum and cortex
CSF in MS
increase myelin basic protein- not specific
-elevated intrathecal IgG, IgM (immunoglobulin)
Sun exposure and potential exposure to MS
greater sun exposure–> lower risk
MHC vitamin D response element in the promotor region of HLA-DRB1
-the risk of developing MS significantly decreased with increasing baseline levels of serum vitamin D
What type of cells are the current target of disease modifying therapies for MS
B CELLS
- Can act as antigen-presenting cells to T cells via MHC
LOOK TO NOTE SHEET FOR INFO ON DMTS AND MEDS
YEP